| Submission | Feb. 27, 2025 |
| Submission [Line Items] | |
| Central Index Key | 0001612042 |
| Registrant Name | Ascendis Pharma A/S |
| Form Type | S-8 |
| Submission Type | S-8 |
| Fee Exhibit Type | EX-FILING FEES |
| Offerings | Feb. 27, 2025 USD ($) shares |
| Offering: 1 | |
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Ordinary shares, DKK 1 nominal value per share |
| Amount Registered | shares | 634,434 |
| Proposed Maximum Offering Price per Unit | 151.96 |
| Maximum Aggregate Offering Price | $ 96,408,590.64 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 14,760.16 |
| Offering Note | * The ordinary shares registered hereby may be represented by the Registrant’s American Depositary Shares (“ADSs”), each of which represents one ordinary share. ADSs issuable upon deposit of the ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 No. 333-201695). (1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional ordinary shares of the Registrant that become issuable under the Ascendis Pharma A/S Restricted Stock Unit Program (the “RSU Program”) and the Ascendis Pharma A/S Performance Stock Unit Program (the “PSU Program”), by reason of any share dividend, share split, bonus issue, recapitalization or similar transaction effected without the Registrant’s receipt of consideration which would increase the number of outstanding ordinary shares. (2) Represents ordinary shares available for future issuance under the RSU Program. (3) Pursuant to 457(c) and 457(h) under the Securities Act, the proposed maximum offering price per share is estimated solely for the purpose of calculating the registration fee and is based upon the average of the high and low prices of the Registrant’s ADSs as reported on the Nasdaq Global Select Market on February 24, 2025, which date is within five business days prior to filing this Registration Statement. (4) Represents ordinary shares represented by ADSs available for future issuance under the PSU Program. (5) The Registrant does not have any fee offsets. |
| Offering: 2 | |
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Ordinary shares, DKK 1 nominal value per share |
| Amount Registered | shares | 73,583 |
| Proposed Maximum Offering Price per Unit | 151.96 |
| Maximum Aggregate Offering Price | $ 11,181,672.68 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 1,711.92 |
| Offering Note | * The ordinary shares registered hereby may be represented by the Registrant’s American Depositary Shares (“ADSs”), each of which represents one ordinary share. ADSs issuable upon deposit of the ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 No. 333-201695). (1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional ordinary shares of the Registrant that become issuable under the Ascendis Pharma A/S Restricted Stock Unit Program (the “RSU Program”) and the Ascendis Pharma A/S Performance Stock Unit Program (the “PSU Program”), by reason of any share dividend, share split, bonus issue, recapitalization or similar transaction effected without the Registrant’s receipt of consideration which would increase the number of outstanding ordinary shares. (3) Pursuant to 457(c) and 457(h) under the Securities Act, the proposed maximum offering price per share is estimated solely for the purpose of calculating the registration fee and is based upon the average of the high and low prices of the Registrant’s ADSs as reported on the Nasdaq Global Select Market on February 24, 2025, which date is within five business days prior to filing this Registration Statement. (4) Represents ordinary shares represented by ADSs available for future issuance under the PSU Program. (5) The Registrant does not have any fee offsets. |
| Fees Summary | Feb. 27, 2025 USD ($) |
| Fees Summary [Line Items] | |
| Total Offering | $ 107,590,263.32 |
| Total Fee Amount | 16,472.08 |
| Total Offset Amount | 0 |
| Net Fee | $ 16,472.08 |
